Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-03-02
1995-03-21
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
549206, 549495, A61K 31555, C07D30752
Patent
active
053995562
ABSTRACT:
The invention relates to salts formed between ranitidine and a complex of zinc with a carboxylic acid selected from tartaric acid, citric acid and alkyl citric acids, and to solvates of such salts. The salts and solvates thereof are useful in the treatment of gastro-intestinal disorders, such as peptic ulcer disease and non-ulcer dyspepsia.
REFERENCES:
patent: 5008256 (1991-04-01), Clitherow
patent: 5041557 (1991-08-01), Vinas
Answer 1, Copyright 1991 American Chemical Society, d acc 100:96486v ab.
Current Trends Review, Drug Development Research 17:185-197 (1989): "Current Views of Zinc as a Gastrohepatic Protective Agent" by C. H. Cho, Dept. of Pharmacology, University of Hong Kong.
Drugs Exptl. Clin. Res. XV(2) 83-89 (1989), "Zinc Compounds, A New Treatment in Peptic Ulcer" by Escolar G. Bulbena O., Dept. of Pharmacology, Laboratorios Vinas S.A., Torrente Vidalet 29, 08012 Barcelona, Spain.
Clitherow John W.
Collington Eric W.
Glaxo Group Ltd.
Ivy C. Warren
Owens A. A.
LandOfFree
Carboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1149057